323 related articles for article (PubMed ID: 30054795)
1. Prognostic value of radiomic analysis of iodine overlay maps from dual-energy computed tomography in patients with resectable lung cancer.
Choe J; Lee SM; Do KH; Lee JB; Lee SM; Lee JG; Seo JB
Eur Radiol; 2019 Feb; 29(2):915-923. PubMed ID: 30054795
[TBL] [Abstract][Full Text] [Related]
2. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
3. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
4. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
5. Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.
Chen YH; Wang TF; Chu SC; Lin CB; Wang LY; Lue KH; Liu SH; Chan SC
PLoS One; 2020; 15(12):e0244502. PubMed ID: 33370365
[TBL] [Abstract][Full Text] [Related]
6. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy.
Bousabarah K; Temming S; Hoevels M; Borggrefe J; Baus WW; Ruess D; Visser-Vandewalle V; Ruge M; Kocher M; Treuer H
Strahlenther Onkol; 2019 Sep; 195(9):830-842. PubMed ID: 30874846
[TBL] [Abstract][Full Text] [Related]
7. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
Khorrami M; Jain P; Bera K; Alilou M; Thawani R; Patil P; Ahmad U; Murthy S; Stephans K; Fu P; Velcheti V; Madabhushi A
Lung Cancer; 2019 Sep; 135():1-9. PubMed ID: 31446979
[TBL] [Abstract][Full Text] [Related]
8. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
9. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
[TBL] [Abstract][Full Text] [Related]
11. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
12. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
[TBL] [Abstract][Full Text] [Related]
13. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT Overcomes Discordance Between Clinical and Pathologic TNM Classification of Small-size Primary Lung Cancer: Influence on Postoperative Prognosis.
Umakoshi H; Iwano S; Yokoi K; Ito S; Ito R; Kawaguchi K; Fukui T; Naganawa S
Clin Lung Cancer; 2018 Jan; 19(1):e37-e45. PubMed ID: 28666761
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy.
Ahn SY; Park CM; Park SJ; Kim HJ; Song C; Lee SM; McAdams HP; Goo JM
Invest Radiol; 2015 Oct; 50(10):719-25. PubMed ID: 26020832
[TBL] [Abstract][Full Text] [Related]
17. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma.
Choi ER; Lee HY; Jeong JY; Choi YL; Kim J; Bae J; Lee KS; Shim YM
Oncotarget; 2016 Oct; 7(41):67302-67313. PubMed ID: 27589833
[TBL] [Abstract][Full Text] [Related]
18. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Signature: A Biomarker for the Preoperative Distant Metastatic Prediction of Stage I Nonsmall Cell Lung Cancer.
Fan L; Fang M; Tu W; Zhang D; Wang Y; Zhou X; Xia Y; Li Z; Liu S
Acad Radiol; 2019 Sep; 26(9):1253-1261. PubMed ID: 30527455
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.
Kim H; Park CM; Keam B; Park SJ; Kim M; Kim TM; Kim DW; Heo DS; Goo JM
PLoS One; 2017; 12(11):e0187500. PubMed ID: 29099855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
